Sabinsa Corporation   Report issue

For profit Phase 1 Phase 2
Founded: East Windsor NJ United States (1988)
Status: No NME R&D (1988)

Organization Overview

First Clinical Trial
2004
NCT00094445
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Sabinsa Corporation

Active Ingredients

Drugs in Phase 2 Trials (1)

curcumin (2 trials)

Drugs in Phase 1 Trials (3)

bacillus coagulans (1 trial)

sorafenib (nexavar) (1 trial)

vorinostat (zolinza) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Pancreatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 4